Apolipoproteins A and B and PCSK9: Nontraditional Cardiovascular Risk Factors in Chronic Kidney Disease and in End-Stage Renal Disease

Figure 5

The biological functions of PCSK9. LDLR: low-density lipoprotein receptor; VLDLRs: very low-density lipoprotein receptors.